TRIMPEX 200 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trimpex 200, and what generic alternatives are available?
Trimpex 200 is a drug marketed by Roche and is included in one NDA.
The generic ingredient in TRIMPEX 200 is trimethoprim. There are thirty-four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trimpex 200
A generic version of TRIMPEX 200 was approved as trimethoprim by DR REDDYS LABS SA on July 30th, 1982.
Summary for TRIMPEX 200
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 172 |
| Patent Applications: | 4,263 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRIMPEX 200 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRIMPEX 200
US Patents and Regulatory Information for TRIMPEX 200
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | TRIMPEX 200 | trimethoprim | TABLET;ORAL | 017952-002 | Nov 9, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
